IP Library Granted Patent US 10,023,678
Granted Patent B2
US 10,023,678 · App. 14/867,114 · Granted Jul 17, 2018

Process for producing flexible polyurethane foam using natural oil polyols

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,023,678
App. No.
14/867,114
Granted
Jul 17, 2018
Kind
B2
Abstract

A composition and process useful to make flexible polyurethane foams and in particular flexible molded polyurethane foams is disclosed. The usage of dipolar aprotic liquids such as DMSO, DMI, sulfolane, N-methyl-acetoacetamide, N, N-dimethylacetoacetamide as well as glycols containing hydroxyl numbers OH#≤1100 as cell opening aides for 2-cyanoacetamide or other similar molecules containing active methylene or methine groups to make a polyurethane foam is also disclosed. The advantage of using cell opener aids results in a) no foam shrinkage; b) lower use levels of cell opener; c) foam performance reproducibility d) optimum physical properties. In addition, combining the acid blocked amine catalyst together with the cell opener and the cell opener aid results in a less corrosive mixture as well as provides a method that does not require mechanical crushing for cell opening.

Claims (15)

1. A process for making polyurethane foam comprising: contacting a composition comprising at least one natural oil polyol, at least one cell opener and at least one cell opener aid, with at least one isocyanate in the presence of tertiary amine catalysts or acid blocked tertiary amine catalysts, wherein the cell opener comprises molecules containing active methylene or methine groups and the cell opener aid comprises at least one member selected from the group consisting of 1,3-dimethyl-2-imidazolidinone, sulfolane, N-methyl-acetoacetamide, and N,N-dimethylacetoacetamide.

2. The process of claim 1 wherein the cell opener comprises 2-cyanoacetamide.

3. The process of claim 1 wherein the catalyst comprises at least one tertiary amine catalyst.

4. The process of claim 1 wherein the natural oil polyol comprises triglycerides of saturated and unsaturated fatty acids.

5. The process of claim 1 wherein the composition further comprises at least one carboxylic acid.

6. The process of claim 1 further comprising molding a polyurethane foam without mechanical crushing in order to open cells within the foam.

7. A process comprising contacting a composition comprising at least one natural oil polyol, at least one copolymer polyol, at least one cell opener, at least one cell opener aid, and at least one tertiary amine catalyst; wherein the cell opener comprises molecules containing active methylene or methine groups and the cell opener aid comprises at least one member selected from the group consisting of 1,3-dimethyl-2-imidazolidinone, sulfolane, N-methyl-acetoacetamide, and N,N-dimethylacetoacetamide, with at least one isocyanate.

8. The process of claim 7 wherein the composition further comprises at least one acid comprising at least one of acetic and formic acids.

9. The process of claim 7 wherein the cell opener comprises 2 cyanoacetamide.

10. The process of claim 1 wherein the composition further comprises at least one copolymer polyol.

11. The process of claim 1 wherein the composition further comprises at least one acid comprising at least one of acetic and formic acids.

12. The process of claim 7 wherein the composition further comprises at least one carboxylic acid.

13. The process of claim 7 wherein the natural oil polyol comprises triglycerides of saturated and unsaturated fatty acids.

14. The process of claim 7 further comprising molding a polyurethane foam without mechanical crushing in order to open cells within the foam.

15. A process for making polyurethane foam comprising contacting a composition comprising at least one natural oil polyol, 2-cyanoacetamide, at least one cell opener aid, at least one tertiary amine catalyst and at least one acid comprising at least one of acetic and formic acids, wherein the cell opener aid comprises at least one member selected from the group consisting of 1,3-dimethyl-2-imidazolidinone, sulfolane, N-methyl-acetoacetamide, and N,N-dimethylacetoacetamide.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 13, 2019
From: EVONIK DEGUSSA GMBH
To: EVONIK OPERATIONS GMBH
Reel/Frame 051284/0491 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 10, 2017
From: BURDENIUC, JUAN JESUS; TOBIAS, JAMES DOUGLAS; KELLER, RENEE JO
To: AIR PRODUCTS AND CHEMICALS, INC.
Reel/Frame 043822/0106 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 4, 2017
From: AIR PRODUCTS AND CHEMICALS, INC.
To: EVONIK DEGUSSA GMBH
Reel/Frame 042402/0301 →